Published in Biochem Pharmacol on September 01, 1992
Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol. Br J Clin Pharmacol (2001) 0.80
Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future. Curr Top Med Chem (2016) 0.75
Amanita phalloides-type mushroom poisoning. West J Med (1982) 2.26
Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal. JAMA (1984) 1.58
Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole. Clin Pharmacol Ther (1977) 1.49
The dopamine transporter gene and Parkinson's disease in a Chinese population. Neurology (1997) 1.43
Management of theophylline overdose patients in the intensive care unit. Anaesth Intensive Care (1992) 1.39
Altered methadone pharmacokinetics in methadone-maintained pregnant women. J Pharmacol Exp Ther (1985) 1.35
Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes. Br J Clin Pharmacol (1991) 1.34
Amatoxin poisoning in northern California, 1982-1983. West J Med (1986) 1.31
Failure of haemoperfusion and haemodialysis to prevent death in paraquat poisoning. A retrospective review of 42 patients. Med Toxicol Adverse Drug Exp (1988) 1.23
Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase. Biochem Pharmacol (1996) 1.18
Experience with 732 acute overdose patients admitted to an intensive care unit over six years. Med J Aust (1993) 1.12
Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients. Cancer Res (1996) 1.11
The epidemiology of Parkinson's disease in an Australian population. Neuroepidemiology (1998) 1.08
First-pass elimination. Basic concepts and clinical consequences. Clin Pharmacokinet (1984) 1.06
Potential pitfalls in the evaluation of the usefulness of hemodialysis for the removal of lithium. J Toxicol Clin Toxicol (1982) 1.05
Diuresis, dialysis, and hemoperfusion. Indications and benefits. Emerg Med Clin North Am (1984) 0.97
Serum formate concentrations in methanol intoxication as a criterion for hemodialysis. Ann Intern Med (1986) 0.95
Toxicologic studies in a fatal overdose of 2,4-D, MCPP, and chlorpyrifos. J Anal Toxicol (1983) 0.93
The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Sci (1997) 0.92
Role of repeated oral doses of activated charcoal in clinical toxicology. Med Toxicol (1986) 0.92
Large scale production and purification of paraquat and desipramine monoclonal antibodies and their Fab fragments. Int J Immunopharmacol (1988) 0.89
"Profiting" from vegetables. J Toxicol Clin Toxicol (1996) 0.89
Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients. J Clin Psychopharmacol (1991) 0.89
Phenytoin-induced methadone withdrawal. Ann Intern Med (1981) 0.89
Purification and characterization of two human liver carboxylesterases. Int J Biochem (1989) 0.89
Removal of theophylline from the body by haemoperfusion. Clin Pharmacokinet (1979) 0.88
Albumin enhances unidirectional fluxes of fatty acid across a lipid-water interface: theory and experiments. Am J Physiol (1989) 0.87
Presystemic metabolism of meperidine to normeperidine in normal and cirrhotic subjects. Clin Pharmacol Ther (1981) 0.87
Quantitative analysis of two pyridinium metabolites of haloperidol in patients with schizophrenia. Clin Pharmacol Ther (1994) 0.87
Activation of the food-derived mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by rabbit and human liver microsomes and purified forms of cytochrome P-450. Carcinogenesis (1989) 0.85
Effects of tricyclic antidepressants on drug metabolism. Clin Pharmacol Ther (1975) 0.84
Two fatalities after acute occupational exposure to ethylene dibromide. JAMA (1984) 0.84
Formation of pyridinium species of haloperidol in human liver and brain. Psychopharmacology (Berl) (1996) 0.84
Biliary excretion of diflunisal conjugates in patients with T-tube drainage. Eur J Clin Pharmacol (1988) 0.83
Theophylline overdose: acute single ingestion versus chronic repeated overmedication. Am J Emerg Med (1985) 0.83
Benefit of hemoperfusion in acute theophylline intoxication. J Toxicol Clin Toxicol (1984) 0.83
Effects on the liver of chemicals encountered in the workplace. West J Med (1982) 0.83
Efficacy of single or repeated hemoperfusion in a canine model of paraquat poisoning. J Pharmacol Exp Ther (1990) 0.83
Cortisol metabolism and its inhibition by glycyrrhetinic acid in the isolated perfused human placental lobule. J Steroid Biochem Mol Biol (1997) 0.82
Combined hepatic and renal injury in alcoholics during therapeutic use of acetaminophen. Arch Intern Med (1985) 0.82
The effects of aging and nutritional state on hypoxia-reoxygenation injury in the perfused rat liver. Transplantation (1994) 0.82
Lack of effect of diazepam on methadone metabolism in methadone-maintained addicts. Clin Pharmacol Ther (1982) 0.81
A high-performance liquid chromatography-electrospray-tandem mass spectrometry analysis of cortisol and metabolites in placental perfusate. Anal Biochem (1997) 0.81
Quantitation of paraquat in biological samples by radioimmunoassay using a monoclonal antibody. Fundam Appl Toxicol (1992) 0.81
The effects of allopurinol and clofibrate on the elimination of coumarin anticoagulants in man. Aust N Z J Med (1975) 0.81
Prevention of paraquat toxicity in suspensions of alveolar type II cells by paraquat-specific antibodies. Hum Exp Toxicol (1994) 0.81
Improved therapeutic drug monitoring of tacrolimus (FK506) by tandem mass spectrometry. Clin Chem (1997) 0.81
Two pyridinium metabolites of haloperidol are present in the brain of patients at post-mortem. Life Sci (1997) 0.81
Metabolic disposition of simvastatin in patients with T-tube drainage. Drug Metab Dispos (1994) 0.81
Clinical and neuropathological abnormalities in baboons treated with HPTP, the tetrahydropyridine analog of haloperidol. Exp Neurol (1999) 0.81
Calibration of albumin-fatty acid binding constants measured by heptane-water partition. Am J Physiol (1993) 0.80
Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidol. Biochem Biophys Res Commun (1991) 0.80
Diflunisal and its conjugates in patients with renal failure. Br J Clin Pharmacol (1991) 0.80
Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.80
Effect of phenytoin on meperidine clearance and normeperidine formation. Clin Pharmacol Ther (1981) 0.79
Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry. Clin Chem (1996) 0.79
The midbrain dopaminergic cell groups in the baboon Papio ursinus. Brain Res Bull (1998) 0.79
Hepatic intracellular pH during the prereplicative period following partial hepatectomy. Am J Physiol (1993) 0.78
Survival after unexpected high serum methotrexate concentrations in a patient with osteogenic sarcoma. Drug Saf (1991) 0.78
Pretreatment with drug-specific antibody reduces desipramine cardiotoxicity in rats. Life Sci (1991) 0.78
Metabolism of haloperidol to pyridinium species in patients receiving high doses intravenously: is HPTP an intermediate? Life Sci (1997) 0.78
Lack of gastrointestinal metabolism of propranolol in dogs after portacaval transposition. J Pharmacol Exp Ther (1982) 0.78
Metabolic drug interactions--a critical review. Med J Aust (1975) 0.78
Studies of protein interactions by biosensor technology: an alternative approach to the analysis of sensorgrams deviating from pseudo-first-order kinetic behavior. Anal Biochem (1997) 0.78
Granulomatous thyroiditis and lithium therapy. Aust N Z J Med (1992) 0.77
Competition between paraquat and putrescine for uptake by suspensions of rat alveolar type II cells. Biochem Pharmacol (1992) 0.77
Reversal of desipramine toxicity in rats using drug-specific antibody Fab' fragment: effects on hypotension and interaction with sodium bicarbonate. J Pharmacol Exp Ther (1992) 0.77
Ethylesterases as indicators of liver damage. I. Studies on malathion carboxylesterases. Toxicol Appl Pharmacol (1982) 0.77
Disposition of epirubicin after intraarterial administration in Lipiodol to patients with hepatocellular carcinoma. Ther Drug Monit (1996) 0.77
Glucose transport and hypoxia-reoxygenation injury in the perfused rat liver. J Gastroenterol Hepatol (1994) 0.77
Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism. J Pharmacokinet Biopharm (1987) 0.77
Redistribution into plasma of tracer doses of desipramine by anti-desipramine antiserum in rats. Biochem Pharmacol (1987) 0.77
Nonlinear relationship between circulating concentrations of reduced haloperidol and haloperidol: evaluation of possible mechanisms. Psychopharmacology (Berl) (1994) 0.77
Dose-dependent sulfoconjugation of salicylamide in dogs: effect of sulfate depletion or administration. J Pharmacol Exp Ther (1985) 0.77
The serotonin transporter gene and Parkinson's disease. Eur Neurol (2000) 0.76
An evaluation of the effects of lithium in the treatment of chronic alcoholism. I. Clinical results. Alcohol Clin Exp Res (1981) 0.76
Comparison of high-performance liquid chromatography and monoclonal fluorescence polarization immunoassay for the determination of whole-blood cyclosporin A in liver and heart transplant patients. Ther Drug Monit (1994) 0.76
The effects of differential induction of cytochrome P-450, carboxylesterase and glutathione S-transferase activities on malathion toxicity in mice. Toxicol Appl Pharmacol (1987) 0.76
Enhanced bioavailability of pethidine and pentazocine in patients with cirrhosis of the liver. Aust N Z J Med (1980) 0.76
Cloning and analysis of a cDNA encoding a human liver carboxylesterase. Gene (1991) 0.76
Determination of methadone and its primary metabolite in biologic fluids using gas chromatography with nitrogen-phosphorus detection. J Anal Toxicol (1982) 0.76
Sensitive high-performance liquid chromatographic assay with ultraviolet detection of methadone enantiomers in plasma. J Chromatogr B Biomed Appl (1994) 0.76
Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.76
Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver. J Pharmacol Exp Ther (1995) 0.76
Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship. Drug Metab Dispos (1991) 0.76
Massive intoxication with acetaminophen and propoxyphene: unexpected survival and unusual pharmacokinetics of acetaminophen. J Toxicol Clin Toxicol (1982) 0.76
Ultrastructure of canine lung during the proliferative phase of paraquat toxicity. Br J Exp Pathol (1988) 0.76
Intestinal infarction complicating phenobarbital overdose. Arch Intern Med (1984) 0.76
Prescription for poisoning. Med J Aust (1995) 0.75
Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions. J Pharmacokinet Biopharm (1984) 0.75
Pharmacokinetics and toxicity of high doses of antibody Fab fragments in rats. Drug Metab Dispos (1988) 0.75
Diltiazem overdose in an elderly patient: efficacy of adrenaline. Anaesth Intensive Care (1992) 0.75
Hemoperfusion in a child who ingested diquat and died from pontine infarction and hemorrhage. J Toxicol Clin Toxicol (1983) 0.75
A technique to study hepatic and intestinal drug metabolism separately in the dog. J Pharmacol Exp Ther (1982) 0.75
An evaluation of the effects of lithium in the treatment of chronic alcoholism. II. Assessment of the two-period crossover design. Alcohol Clin Exp Res (1981) 0.75
Treatment of theophylline overdose. JAMA (1983) 0.75
Diazepam kinetics in acute alcohol withdrawal. Clin Pharmacol Ther (1979) 0.75
Gas chromatographic analysis of meperidine and normeperidine: determination in blood after a single dose of meperidine. J Pharm Sci (1982) 0.75
Bound Tris confounds the identification of binding site residues in a paraquat single chain antibody. J Biochem (1997) 0.75